Measurement of S100A8/S100A9 in feces is considered a reliable method to distinguish IBD patients from those without chronic intestinal inflammation and it is, together with serum levels of S100A8/S100A9, useful in monitoring inflammation in patients with Crohn’s disease or ulcerative colitis [130]. This evidence concerns the gene S100A8 and Crohn disease.